Type XIX collagen: a promising biomarker from the basement membranes

Calvo, Ana Cristina (Universidad de Zaragoza) ; Moreno, Laura ; Moreno, Leticia (Universidad de Zaragoza) ; Toivonen, Janne (Universidad de Zaragoza) ; Manzano, Raquel (Universidad de Zaragoza) ; Molina, Nora ; de la Torre, Miriam (Universidad de Zaragoza) ; Lopez, Tresa (Universidad de Zaragoza) ; Miana-Mena, Francisco Javier (Universidad de Zaragoza) ; Muñoz, María Jesús ; Zaragoza, Pilar (Universidad de Zaragoza) ; Larrodé, Pilar (Universidad de Zaragoza) ; García-Redondo, Alberto ; Osta, Rosario (Universidad de Zaragoza)
Type XIX collagen: a promising biomarker from the basement membranes
Resumen: Among collagen members in the collagen superfamily, type XIX collagen has raised increasing interest in relation to its structural and biological roles. Type XIX collagen is a Fibril-Associated Collagen with Interrupted Triple helices member, one main subclass of collagens in this superfamily. This collagen contains a triple helix composed of three polypeptide segments aligned in parallel and it is associated with the basement membrane zone in different tissues. The molecular structure of type XIX collagen consists of five collagenous domains, COL1 to COL5, interrupted by six non-collagenous domains, NC1 to NC6. The most relevant domain by which this collagen exerts its biological roles is NC1 domain that can be cleavage enzymatically to release matricryptins, exerting anti-tumor and anti-angiogenic effect in murine and human models of cancer. Under physiological conditions, type XIX collagen expression decreases after birth in different tissues although it is necessary to keep its basal levels, mainly in skeletal muscle and hippocampal and telencephalic interneurons in brain. Notwithstanding, in amyotrophic lateral sclerosis, altered transcript expression levels show a novel biological effect of this collagen beyond its structural role in basement membranes and its anti-tumor and anti-angiogenic properties. Type XIX collagen can exert a compensatory effect to ameliorate the disease progression under neurodegenerative conditions specific to amyotrophic lateral sclerosis in transgenic SOD1G93A mice and amyotrophic lateral sclerosis patients. This novel biological role highlights its nature as prognostic biomarker of disease progression in and as promising therapeutic target, paving the way to a more precise prognosis of amyotrophic lateral sclerosis.
Idioma: Inglés
DOI: 10.4103/1673-5374.270299
Año: 2020
Publicado en: NEURAL REGENERATION RESEARCH 15, 6 (2020), 988-995
ISSN: 1673-5374

Factor impacto JCR: 5.135 (2020)
Categ. JCR: NEUROSCIENCES rank: 78 / 273 = 0.286 (2020) - Q2 - T1
Categ. JCR: CELL BIOLOGY rank: 78 / 195 = 0.4 (2020) - Q2 - T2

Factor impacto SCIMAGO: 0.93 - Developmental Neuroscience (Q2)

Financiación: info:eu-repo/grantAgreement/ES/FIS-FEDER/PI17-00949
Tipo y forma: Article (Published version)
Área (Departamento): Área Genética (Dpto. Anatom.,Embri.Genét.Ani.)
Área (Departamento): Área Fisiología (Dpto. Farmacología y Fisiolog.)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

Exportado de SIDERAL (2023-02-10-14:00:08)

Este artículo se encuentra en las siguientes colecciones:

 Record created 2020-01-03, last modified 2023-02-10

Versión publicada:
Rate this document:

Rate this document:
(Not yet reviewed)